{"pageContent": "Purpose of review: Focal therapy aims to reduce side-effects of active whole-gland therapies with an acceptable or noninferior oncologic benefit for the patient. The definition of the lesion to treat using this tissue-preserving approach is central, and there is a recent shift in considering more aggressive disease than in the past. This article examines recent consensus reports, assessment of emerging techniques, histologic considerations as well as results of trials and their development.", "metaData": {"source": "Evolution of precise and multimodal MRI and TRUS in detection and management of early prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/20583890/"}}